The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Radiation treatment inhibits monocyte entry into the optic nerve head and prevents neuronal damage in a mouse model of glaucoma
Open accessAbstract
Glaucoma is a common ocular disorder that is a leading cause of blindness worldwide. It is characterized by the dysfunction and loss of retinal ganglion cells (RGCs). Although many studies have implicated various molecules in glaucoma, no mechanism has been shown to be responsible for the earliest detectable damage to RGCs and their axons in the optic nerve. Here, we show that the leukocyte transendothelial migration pathway is activated in the optic nerve head at the earliest stages of disease in an inherited mouse model of glaucoma. This resulted in proinflammatory monocytes entering the optic nerve prior to detectable neuronal damage. A 1-time x-ray treatment prevented monocyte entry and subsequent glaucomatous damage. A single x-ray treatment of an individual eye in young mice provided that eye with long-term protection from glaucoma but had no effect on the contralateral eye. Localized radiation treatment prevented detectable neuronal damage and dysfunction in treated eyes, despite the continued presence of other glaucomatous stresses and signaling pathways. Injection of endothelin-2, a damaging mediator produced by the monocytes, into irradiated eyes, combined with the other glaucomatous stresses, restored neural damage with a topography characteristic of glaucoma. Together, these data support a model of glaucomatous damage involving monocyte entry into the optic nerve.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical significance for genomewide studies
Storey, J. D., & Tibshirani, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530509100 · Cited by 9,692 · cited 1×
“adjusted using the false discovery rate (FDR) method (92) implemented in”
MethodMolecular dissection of reactive astrogliosis and glial scar formation
Sofroniew, M. V. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.08.002 · Cited by 2,594 · cited 1×
“In addition to endothelial cells and leukocytes, neuroinflammatory processes are likely to be controlled and mediated by both microglia and astrocytes (34, 51) in the ONH during glaucoma.”
BackgroundMicroglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543 · cited 1×
“In addition to endothelial cells and leukocytes, neuroinflammatory processes are likely to be controlled and mediated by both microglia and astrocytes (34, 51) in the ONH during glaucoma.”
BackgroundSelectins and their ligands: Current concepts and controversies
Kansas, G. (1996) · Blood · doi:10.1182/blood.v88.9.3259.bloodjournal8893259 · Cited by 1,415
Astrocytes are active players in cerebral innate immunity
Farina, C., Aloisi, F., & Meinl, E. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.01.005 · Cited by 1,304
Howell, G. R., Macalinao, D. G., Sousa, G. L., Walden, M., Soto, I., Kneeland, S. C., Barbay, J. M., King, B. L., Marchant, J. K., Hibbs, M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44646 · Cited by 473
Self-citationMicroarray analysis of retinal gene expression in the DBA/2J model of glaucoma
Steele, M. R., Inman, D. M., Calkins, D. J., Horner, P. J., & Vetter, M. L. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0865 · Cited by 196
Cited by
Retinal microglia: Just bystander or target for therapy?
Karlstetter, M., Scholz, R., Rutar, M., Wong, W. T., Provis, J. M., & Langmann, T. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.11.004 · Cited by 551
The role of microglia in retinal neurodegeneration: Alzheimer’s disease, parkinson, and glaucoma.
Ramirez, A. I., de Hoz, R., Salobrar-Garcia, E., Salazar, J. J., Rojas, B., Ajoy, D., López-Cuenca, I., Rojas, P., Triviño, A., & Ramírez, J. M. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00214 · Cited by 466
Inflammation in Glaucoma: From the back to the front of the eye, and beyond
Baudouin, C., Kolko, M., Melik-Parsadaniantz, S., & Messmer, E. M. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100916 · Cited by 454
Microglia in the Retina: Roles in Development, Maturity, and Disease
Silverman, S. M., & Wong, W. T. (2018) · Annual Review of Vision Science · doi:10.1146/annurev-vision-091517-034425 · Cited by 346
Nickells, R. W., Howell, G. R., Soto, I., & John, S. W. M. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135728 · Cited by 336
Self-citationCritical pathogenic events underlying progression of neurodegeneration in glaucoma
Calkins, D. J. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2012.07.001 · Cited by 309
Neuroinflammation in glaucoma: A new opportunity
Williams, P. A., Marsh-Armstrong, N., Howell, G. R., Bosco, A., Danias, J., Simon, J., Di Polo, A., Kuehn, M. H., Przedborski, S., Raff, M., et al. (2017) · Experimental Eye Research · doi:10.1016/j.exer.2017.02.014 · Cited by 253
“Recent studies have shown infiltration of leukocytes into the ONH and retina may be key events in glaucoma (Howell et al., 2012; Astafurov et al., 2014).”
BackgroundSelf-citationMiner, J. J., Daniels, B. P., Shrestha, B., Proenca-Modena, J. L., Lew, E. D., Lazear, H. M., Gorman, M. J., Lemke, G., Klein, R. S., & Diamond, M. S. (2015) · Nature Medicine · doi:10.1038/nm.3974 · Cited by 152
Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin
Harder, J. M., Guymer, C., Wood, J. P. M., Daskalaki, E., Chidlow, G., Zhang, C., Balasubramanian, R., Cardozo, B. H., Foxworth, N. E., Deering, K. E., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2014213117 · Cited by 127
“In addition to a major role in energy metabolism, pyruvate has been shown to protect against PARP activation, oxidative stress, and neuroinflammation (10, 11), all of which have been associated with glaucoma (12 – 15).”
Self-citationCueva Vargas, J. L., Osswald, I. K., Unsain, N., Aurousseau, M. R., Barker, P. A., Bowie, D., & Di Polo, A. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.1273-15.2015 · Cited by 132
“Of interest, high-dose irradiation leading to reduced microglial activation, and presumably decreased levels of proinflammatory mediators, attenuated RGC degeneration in a mouse model of inherited pigmentary glaucoma (Bosco et al., 2012; Howell et al., 2012).”
BackgroundMargeta, M. A., Yin, Z., Madore, C., Pitts, K. M., Letcher, S. M., Tang, J., Jiang, S., Gauthier, C. D., Silveira, S. R., Schroeder, C. M., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.07.014 · Cited by 130
Proximal inhibition of p38 MAPK stress signaling prevents distal axonopathy
Dapper, J. D., Crish, S. D., Pang, I.-H., & Calkins, D. J. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.07.001 · Cited by 76
“Explants were processed with a nonradioactive p38 MAPK assay kit to assess specific activation of the kinase and to demonstrate specificity of Ro3206145 in our hands (Cell Signaling Technology, Beverly, MA: Hsieh and Papaconstantinou, 2006; Ding et al., 2009).”
More than meets the eye: The role of microglia in healthy and diseased retina
Murenu, E., Gerhardt, M.-J., Biel, M., & Michalakis, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1006897 · Cited by 73
Karlen, S. J., Miller, E. B., Wang, X., Levine, E. S., Zawadzki, R. J., & Burns, M. E. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1365-4 · Cited by 71
Krishnan, A., Fei, F., Jones, A., Busto, P., Marshak-Rothstein, A., Ksander, B. R., & Gregory-Ksander, M. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1601488 · Cited by 68
“Enhanced RGC survival was also observed in mouse models of glaucoma in which the infiltration of macrophages, present in human and experimental models of glaucoma (13–15), was inhibited through the use of Mac1 mice (13) or ocular irradiation (15).”
BackgroundJackson, H. M., Soto, I., Graham, L. C., Carter, G. W., & Howell, G. R. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-831 · Cited by 66
Self-citationJUN is important for ocular hypertension-induced retinal ganglion cell degeneration
Syc-Mazurek, S. B., Fernandes, K. A., & Libby, R. T. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.338 · Cited by 53
Self-citationPan, L., Cho, K.-S., Wei, X., Xu, F., Lennikov, A., Hu, G., Tang, J., Guo, S., Chen, J., Kriukov, E., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112889 · Cited by 52
Harder, J. M., Williams, P. A., Soto, I., Foxworth, N. E., Fernandes, K. A., Freeburg, N. F., Libby, R. T., & John, S. W. M. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0705-8 · Cited by 23
Self-citation
Metadata
- Authors
- Howell, G. R., Soto, I., Zhu, X., Ryan, M., Macalinao, D. G., Sousa, G. L., Caddle, L. B., MacNicoll, K. H., Barbay, J. M., Porciatti, V., Anderson, M. G., Smith, R. S., Clark, A. F., Libby, R. T., & John, S. W. M.
- Venue
- Journal of Clinical Investigation
- Published
- 2012-04-02
- Volume
- 122
- Issue
- 4
- Pages
- 1246-1261
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1996690280
- Cited by
- 232
- References
- 7
- FWCI
- 17.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.